Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0623
-0.0577 (-48.08%)
At close: Jun 26, 2026
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $356.07 thousand as of June 29, 2026. Its market cap has decreased by -42.55% in one year.
Market Cap
356.07K
Enterprise Value
1.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 356.07K, a decrease of -99.79%. That is a compound annual growth rate of -40.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 356.07K | -32.64% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 593.88K |
| Sorrento Therapeutics | 543.71K |
| CERo Therapeutics Holdings | 515.71K |
| Nextel Medical | 442.78K |
| Lipella Pharmaceuticals | 415.88K |
| Helix BioMedix | 402.23K |
| Actavia Life Sciences | 385.91K |
| IO Biotech | 366.94K |